Navigation Links
TrialNetworks Customer to Present Results of Using Site Engagement Technology to Improve Study Operations and Patient Enrollment at Clinical Trial Optimization Conference
Date:9/27/2013

Needham, MA (PRWEB) September 27, 2013

TrialNetworks, an innovative technology company which provides the global pharmaceutical industry’s only Clinical Trial Optimization System, will sponsor and actively participate in the following prominent and collaborative events next month:

At Clinical Trial Optimization, a top-10 pharmaceutical company will present findings on using TrialNetworks technology to improve patient enrollment and trial execution in a global study. The TrialNetworks system is used by study sponsors from small biotechs to large global pharmas to optimize operations from startup through closeout – including feasibility, site activation, patient recruitment and retention, site engagement, trial conduct, online training, document management and more – all integrated within one centralized cloud-based platform.

Eric Silberstein, TrialNetworks CEO, said, “Our team is comprised of expert technologists with a deep understanding and appreciation of clinical research, and former study practitioners who are passionate about using technology to improve trial operations. We place tremendous value on sponsoring industry conferences because they provide an ideal opportunity to build strong relationships with key opinion leaders and learn about the evolving challenges our customers face.”

About TrialNetworks
TrialNetworks provides sponsors and CROs the industry's only Clinical Trial Optimization System. Using modern and intuitive technology, the TrialNetworks platform increases the quality and efficiency of clinical operations at each stage of a trial from feasibility through closeout. TrialNetworks apps, including Checklist, Document Library, Visit Guide, Action Items and Directory, are available in a unified and secure cloud-based interface. Customers ranging from Top 10 pharmaceutical companies to biotechs have implemented the TrialNetworks platform for use in Phase I-IV studies by more than 20,000 site staff in 60 countries. To learn why sponsors rely on TrialNetworks to optimize clinical trial operations, request a personalized demo at http://www.trialnetworks.com.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11169647.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Customer Satisfaction, A key to Success: Narang Medical Limited
2. TAKE Solutions Brings Together Leading Experts and TAKE Customers at “Converge 2012” to Discuss Business
3. Transportation and Energy Customers Look to Wharfedale’s SAP® Solutions with an Eye toward Cost Savings and Improved Operational Efficiencies
4. Sangui Bio Tech International Inc. - Over 500 Customers: Granulox Sales Ahead of Planning
5. Z Trim Holdings Grows Customer Base
6. BioInformatics LLC Announces New Market Report – Enhancing the Customer Experience: Insights and Life Science Supplier Rankings (13-002)
7. SoundConnect Announces New Not-For-Profit Customer in Smart Card Alliance
8. Rusterizer Gives Out Complimentary Rust Removers to First 100 Customers, My Cleaning Products Shares the Details
9. Puritan Medical Products Launches New Series to Tell Customer Stories
10. Veeva CRM Adds New Survey Functionality to Deepen Customer Understanding and Drive More Relevant Interactions
11. Centius – Partners with Engaged Nation– a Leading Gaming Industry Customer Loyalty Solution Provider to Help Maximize Customer Lifetime Value
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Oakland, California (PRWEB) , ... March 28, 2017 , ... ... that its flagship product, AllegroGraph , has been named a ‘Champion’ by Bloor ... “AllegroGraph is the highest ranked product in its class, and, thanks to Gruff, it ...
(Date:3/28/2017)... WASHINGTON , March 28, 2017  (AACR17, Booth ... sequencing during the American Association for Cancer Research (AACR) ... in Washington, D.C. , April 1-5, ... expression of thousands of cells at the individual level. ... Experts on-hand at AACR to discuss expanded next ...
(Date:3/28/2017)... HOLLISTON, Mass. , March 28, 2017 ... "Company"), a biotechnology company developing bioengineered organ implants to ... bronchus and trachea, today announced that Jim McGorry, ... 3D Printing and BioEngineering panel at the ... 2017 at 2:30 PM ET in Cambrige, Massachussetts. The ...
(Date:3/28/2017)... 2017 /PRNewswire/ -RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) ... safety and clinical data from its phase 1/2 tendon repair ... follicle-derived fibroblasts (RCT-01) as a treatment for Achilles tendinosis. ... The ... profile at 6 months and showed no serious adverse events ...
Breaking Biology Technology:
(Date:3/2/2017)... March 2, 2017 Summary This report ... and its partnering interests and activities since 2010. ... Read the full ... Alliance since 2010 report provides an in-depth insight into the ... companies. On demand company reports are prepared upon ...
(Date:3/2/2017)... March 2, 2017 Who risk to be ... Download the full report: https://www.reportbuyer.com/product/4313699/ WILL ... SENSOR FIELD? Fingerprint sensors using capacitive technology represent ... sensor vendor Idex forecasts an increase of 360% of ... and of the fingerprint sensor market between 2014 and ...
(Date:3/1/2017)... 2017  Aware, Inc. (NASDAQ: AWRE), a leading supplier ... P. Moberg has resigned, effective March 3, 2017, ... Officer and Treasurer of Aware citing a desire to ... member of the Board of Directors of Aware. ... Officer and co-President, General Counsel has been named Chief ...
Breaking Biology News(10 mins):